Baker Bros. Advisors buys $32.31 million of Kodiak Sciences common shares
Bitget2026/09/30 20:30- Baker Bros. Advisors, a Kodiak Sciences director-level 10% owner group, reported net purchases of 702,981 common shares.
- Purchases executed at weighted-average prices of USD 61.2104 to USD 78.5681 per share.
- Holdings rose to 1,605,892 shares in 667, L.P. accounts, 19,121,134 shares in Baker Brothers Life Sciences fund accounts.
- Filings list Felix J. Baker as a Kodiak Sciences director.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Simwon America (SWA.US) applies for Nasdaq IPO, plans to raise up to $50 million
Simwon America, a manufacturer of structural components for electric vehicles, filed for an IPO with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to $50 million. The company is a spinoff of Korea’s MS Autotech.
Sui Foundation Invests $30M in DATA Network as It Moves to Sui post-167040 post-167040 post-167040
Equities: Stable oil and yields support stock gains - Danske Bank
Dental caries treatment provider vVardis (VVVV.US) submits US IPO application, expected to raise 200 million USD
vVardis Holding filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday. The company focuses on self-developed non-invasive restorative therapies for the early treatment of dental caries. The IPO is expected to raise 200 millions USD.
Crypto prices
More
